PLoS ONEGeneticsPeer-reviewed journal article
The effect of ascertainment on penetrance estimates for rare variants: implications for establishing pathogenicity and for genetic counselling
Andrew D. PatersoniD, Sang-Cheol SeokiD, Veronica J. VielandiD
Abstract
Next-generation sequencing has led to an explosion of genetic findings for many rare diseases. However, most of the variants identified are very rare and were identified in small pedigrees, which creates challenges in terms of penetrance estimation and translation into genetic counselling in the setting of cascade testing. We use simulations to show that for a rare (dominant) disorder where a variant is identified in a small number of small pedigrees, the penetrance estimate can both have large uncertainty and be drastically inflated, due to underlying ascertainment bias. We have developed PenEst, an app that allows users to investigate the phenomenon across ranges of parameter settings. We also illustrate robust ascertainment corrections via the LOD score, and recommend a LOD-based approach to assessing pathogenicity of rare variants in the presence of reduced penetrance.
- Citations
- 6
- FWCI
- 0.99
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Calculating variant penetrance using family history of disease and population data
Thomas P Spargo, Sarah Opie-Martin, … Ammar Al‐Chalabi·Genome MedicinePeer-reviewed·Dec 15, 2022
- Assessing the pathogenicity, penetrance and expressivity of putative disease-causing variants in a population setting
Caroline Fiona Wright, Ben West, … Michael N. Weedon·The American Journal of Human GeneticsPeer-reviewed·Jan 18, 2019
- Calculating the statistical significance of rare variants causal for Mendelian and complex disorders
Aliz R. Rao, Stanley F. Nelson·BMC Medical GenomicsPeer-reviewed·Jun 13, 2018
- Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Roddy Walsh, Kate Thomson, … Hugh C Watkins·Genetics in MedicinePeer-reviewed·Feb 1, 2017
- Molecular Diagnosis as a Probability of Necessity
John W. Belmont, C.J. Williams, Chad A. Shaw·medRxiv·Oct 4, 2026
- A population-based resource for the prioritization of rare variants of unknown significance in clinical genomics
Sarah Tremblay, Claudia Moreau, … Simon L Girard·medRxiv·Nov 4, 2026